TRUP
AI MemoPost-earnings T+1Trupanion
As of 2026-11-06/Post-earnings T+1/Confidence medium
Data freshness
AI Memo
As of 2026-11-06 • Model: RankAlpha Sentiment Codex
Decision Panel
Action, confidence, horizon, and decision blockers at a glance.
Action
—
Confidence
medium
Horizon
—
Key catalyst
Q3 earnings beat, followed by a volatile share-price reaction • 2026-11-06
Base target: $38 / p=45% prob
Biggest risk
Total enrollment still declined 2% year over year despite subscription growth [#SEC-8K-2026-11-05] (SEC earnings exhibit). The sharp reversal between after-hours and intraday trading makes a settled post-print interpretation premature. No verified post-print analyst rating, target, or estimate revision was found.
Invalidation
Break below $28 or thesis failure.
What would change my mind?
The EPS and revenue beats, higher Q3 free cash flow of $28.5 million, and subscription growth support the positive directional prior [#SEC-8K-2026-11-05] (SEC earnings exhibit). Management’s Q4 outlook provides a measurable follow-through test [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript).
Research note
Recommendation
—
Confidence
medium
As of
2026-11-06
Base target
$38
p=45%
Bull target
$45
p=30%
Bear target
$28
p=25%
Key bullets
Fast scan of bull, bear, and watch items
BullKey bullets
- Subscription retention and acquisition efficiency
- The EPS and revenue beats, higher Q3 free cash flow of $28.5 million, and subscription growth support the positive directional prior [#SEC-8K-2026-11-05] (SEC earnings exhibit).
- Management’s Q4 outlook provides a measurable follow-through test [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript).
BearKey bullets
- Higher veterinary claims costs or weaker pricing and retention could erode the improvement in subscription economics.
- Q4 adjusted operating income must reach management’s $48 million–$51 million range to validate the stronger-profitability thesis [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript).
- The remaining $75 million repurchase authorization is discretionary, not a commitment to spend [#SEC-8K-2026-11-05] (SEC earnings exhibit).
WatchKey bullets
- Q3 earnings beat, followed by a volatile share-price reaction
Summary
High-level snapshot
Recommendation
-
Model confidence
medium
Timeframe
-
Asset
Equity
Trigger
Post-earnings T+1
Base case: $38 (p=45%)
Target spread vs base: +18% / -26%
Scenario probabilities
Bull Target: $45 (p=30%)Base Target: $38 (p=45%)Bear Target: $28 (p=25%)
Commentary
The print beat the cited pre-release EPS and revenue estimates, but price discovery was unsettled: the stock was around $31.50 after hours on November 5 versus its $34.72 close, then reached $38.14 (+9.85% versus that close) at 18:41 UTC on November 6; neither quote establishes a post-release closing return (after-hours quote). No verified post-print analyst revisions or target changes were available. The packet’s deterministic prior is positive and its evidence-quality score is high, but this T+1 view remains cautious until the market reaction and Q4 outlook are tested.
As of 2026-11-06 • Updated bi-weekly / post-earningsSource: Internal modelMethodology
Analyst Summary
Thesis highlights from the latest analysis
Bull Case
The EPS and revenue beats, higher Q3 free cash flow of $28.5 million, and subscription growth support the positive directional prior [#SEC-8K-2026-11-05] (SEC earnings exhibit). Management’s Q4 outlook provides a measurable follow-through test [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript).
Bear Case
Total enrollment still declined 2% year over year despite subscription growth [#SEC-8K-2026-11-05] (SEC earnings exhibit). The sharp reversal between after-hours and intraday trading makes a settled post-print interpretation premature. No verified post-print analyst rating, target, or estimate revision was found.
Drivers
Scannable catalysts and supporting factors
- Subscription retention and acquisition efficiency
Scenarios
Bull Target (Scenario probability)
$45 / p=30% prob
Base Target (Scenario probability)
$38 / p=45% prob
Bear Target (Scenario probability)
$28 / p=25% prob
Analysis 2026-11-06 · RankAlpha Sentiment Codex
Analysis reference price unavailable. Targets are shown without scenario returns.
Sentiment & Exposure
News Sentiment (30d)
0.35
Social Sentiment (7d)
0.00
Events
Other notable items detected
- EVENT2026-11-06Q3 earnings beat, followed by a volatile share-price reactionTrupanion reported Q3 revenue of $405.6 million and diluted EPS of $0.21 [#SEC-8K-2026-11-05] (SEC earnings exhibit). That exceeded the cited pre-release consensus of $402.16 million and $0.16, respectively (Zacks preview). Shares fell about 9% after hours on November 5 but traded about 10% above the $34.72 pre-release close at 18:41 UTC on November 6; the intraday gain is not a closing reaction (after-hours quote).Prob 100.00% • Move 0.00% • Priced-in 65.00%
- EVENT2026-12-31Q4 operating-income outlook tests the earnings interpretationOn the Q3 call, management forecast Q4 revenue of $407 million–$414 million and adjusted operating income of $48 million–$51 million; it put full-year adjusted operating income at $179 million–$182 million [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript). Delivery against those ranges matters more than the initial EPS beat.Prob 70.00% • Move 8.00% • Priced-in 45.00%
Short-term Catalysts
Next few weeks
No short-term catalysts
Long-term Catalysts
Months to a year
- Subscription retention and acquisition efficiency2027-03-01Q3 subscription revenue rose 14% year over year and subscription enrollment rose 6%, while total enrollment fell 2% [#SEC-8K-2026-11-05] (SEC earnings exhibit). Management said retention improved for a seventh consecutive quarter and attributed lower acquisition cost per pet partly to better conversion [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript). Sustaining both trends is the longer-term test.Prob 60% • Move 12% • Priced-in 40%
Risks
- Higher veterinary claims costs or weaker pricing and retention could erode the improvement in subscription economics.
- Q4 adjusted operating income must reach management’s $48 million–$51 million range to validate the stronger-profitability thesis [#EARNINGS-TRANSCRIPT-2026Q3] (Q3 call transcript).
- The remaining $75 million repurchase authorization is discretionary, not a commitment to spend [#SEC-8K-2026-11-05] (SEC earnings exhibit).
- Total enrolled pets declined 2% year over year even as subscription pets grew 6% [#SEC-8K-2026-11-05] (SEC earnings exhibit).
Peers
| Symbol | Summary |
|---|---|
| SAFT | Insurance-sector, similar-market-cap reference from the packet, but not a direct pet-insurance operating peer; underwriting and growth comparisons need caution. |
| UVE | Insurance-sector, similar-market-cap reference from the packet, but its business mix is not a close substitute for Trupanion’s pet subscriptions. |
Sources
Internal and external references used in this analysis
- Model source: RankAlpha Sentiment Codex
- Analysis date: 2026-11-06